Astrana Health (NASDAQ:ASTH) Hits New 12-Month Low Following Weak Earnings

Astrana Health, Inc. (NASDAQ:ASTH)’s share price hit a new 52-week low during trading on Friday following a weaker than expected earnings announcement. The company traded as low as $25.59 and last traded at $25.73, with a volume of 62907 shares changing hands. The stock had previously closed at $34.68.

The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). The firm had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%.

Wall Street Analyst Weigh In

Several research firms recently commented on ASTH. Macquarie upgraded shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Stifel Nicolaus decreased their price target on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Truist Financial decreased their price target on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Finally, Robert W. Baird raised their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $65.60.

Institutional Trading of Astrana Health

Institutional investors have recently added to or reduced their stakes in the business. Janus Henderson Group PLC acquired a new stake in Astrana Health in the third quarter valued at approximately $1,164,000. Royce & Associates LP acquired a new stake in shares of Astrana Health in the third quarter worth $6,661,000. Amalgamated Bank acquired a new stake in shares of Astrana Health in the third quarter worth $713,000. Principal Financial Group Inc. acquired a new stake in shares of Astrana Health in the third quarter worth $13,383,000. Finally, Loomis Sayles & Co. L P acquired a new stake in shares of Astrana Health in the third quarter worth $30,251,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Price Performance

The stock’s 50 day moving average price is $35.01 and its two-hundred day moving average price is $44.65. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of 19.52, a PEG ratio of 1.37 and a beta of 1.20.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.